Twareat Medical Care Company (TADAWUL:9627)

TADAWUL:9627 Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	23.51	14.17	25.43
Depreciation & Amortization	4	3.12	1.56
Loss (Gain) From Sale of Assets	-	-	-0
Provision & Write-off of Bad Debts	1.03	2.46	6.07
Other Operating Activities	1.59	0.93	1.63
Change in Accounts Receivable	-27.39	-14.42	-2.65
Change in Inventory	0.12	-0.2	-0.91
Change in Accounts Payable	5.28	2.38	2.32
Change in Unearned Revenue	-0.3	0.64	-
Change in Other Net Operating Assets	0.72	0.04	-2.38
Operating Cash Flow	8.57	9.12	31.05
Operating Cash Flow Growth	-5.96%	-70.64%	-
Capital Expenditures	-6.04	-7.64	-12.52
Sale of Property, Plant & Equipment	-	-	0.03
Sale (Purchase) of Intangibles	-0.02	-0.31	-0.09
Investing Cash Flow	-6.05	-7.95	-12.57
Short-Term Debt Issued	8.41	0.88	-
Long-Term Debt Issued	-	-	1.54
Total Debt Issued	8.41	0.88	1.54
Short-Term Debt Repaid	-1.87	-	-4.31
Long-Term Debt Repaid	-0.95	-4.57	-0.66
Total Debt Repaid	-2.82	-4.57	-4.97
Net Debt Issued (Repaid)	5.59	-3.69	-3.43
Common Dividends Paid	-8.1	-8.24	-3.2
Financing Cash Flow	-2.51	-11.93	-6.63
Net Cash Flow	0.01	-10.76	11.85
Free Cash Flow	2.54	1.48	18.54
Free Cash Flow Growth	71.83%	-92.03%	-
Free Cash Flow Margin	1.32%	0.95%	12.40%
Free Cash Flow Per Share	0.06	0.04	-
Cash Interest Paid	0.33	0.27	0.55
Levered Free Cash Flow	-8.35	-3.39	-
Unlevered Free Cash Flow	-7.95	-3.06	-
Change in Net Working Capital	21.68	8.12	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.